DalsnaFinance

Intelivation Technologies Announces First Clinical Use of Advantage-C™ Ti3D Cervical Interbody Device

Markets PR Newswire By PR Newswire 25 Jun 2026 21:05 1 min read
Intelivation Technologies Announces First Clinical Use of Advantage-C™ Ti3D Cervical Interbody Device

PLYMOUTH MEETING, Pa., June 25, 2026 /PRNewswire/ -- Intelivation Technologies today announced the successful first clinical use of its Advantage-C™ Ti3D Cervical Interbody Device. The Advantage-C™ Ti3D is a 3D-printed titanium cervical cage designed to support fusion. Its scalloped wall...

PLYMOUTH MEETING, Pa., June 25, 2026 /PRNewswire/ -- Intelivation Technologies today announced the successful first clinical use of its Advantage-C™ Ti3D Cervical Interbody Device. The Advantage-C™ Ti3D is a 3D-printed titanium cervical cage designed to support fusion. Its scalloped wall...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.